Medical News

RSS

Ingredient in cough medicine could treat prostate cancer

A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer.

22 Dec 2008

Foreign-born workers report lower rate of non-fatal work-related injuries than U.S.-born workers

A new study funded by U.S. National Institute for Occupational Safety and Health reports that foreign-born workers reported a lower rate of non-fatal work-related injuries than U.S.-born workers, based on data collected from the National Health Interview Survey from 1997 to 2005.

22 Dec 2008

Carbon nanotubes show promise in emerging field of neuro-engineering and neuroprosthetics

Research done by scientists in Italy and Switzerland has shown that carbon nanotubes may be the ideal "smart" brain material.

22 Dec 2008

Hexokinase-1 gene variation associated with widely used marker of blood glucose concentration

Scientists have found that genetic variation at the hexokinase-1 gene is linked to variation in the blood concentration of glycated hemoglobin, an index of long-term blood glucose concentration widely used in the follow-up of diabetes patients.

22 Dec 2008

Adults with asthma at increased risk of serious pneumococcal disease

Mayo Clinic research shows adults with asthma are at increased risk of serious pneumococcal disease caused by Streptococcus pneumoniae, the most common bacteria causing middle ear infections and community acquired pneumonia.

22 Dec 2008

Johnson & Johnson extends cash tender offer for Omrix Biopharmaceuticals

Johnson & Johnson has announced it has extended its previously announced cash tender offer, through its wholly-owned subsidiary, Binder Merger Sub, Inc., for all outstanding shares of common stock of Omrix Biopharmaceuticals, Inc. until 12:00 midnight (Eastern time), on Dec. 26, 2008, unless further extended.

22 Dec 2008

Immunogenicity and safety of human papillomavirus vaccine in healthy boys

New industry-supported research from Finland suggests that Cervarix, an HPV vaccine given to girls in Europe and elsewhere, is safe for boys as well.

21 Dec 2008

How mirror neurons allow us to learn and socialize by going through the motions in the head

The old adage that we can only learn how to do something by trying it ourselves may have to be revised in the light of recent discoveries in neuroscience.

21 Dec 2008

GlaxoSmithKline ready to supply Biota's Relenza to meet CDC recommendations

GlaxoSmithKline (GSK) is prepared to respond to public health needs for Relenza (zanamivir) Inhalation Powder this flu season following a Health Alert Advisory issued by the Centers for Disease Control and Prevention (CDC).

21 Dec 2008

Miniature therapeutic ultrasound device

A prototype of a therapeutic ultrasound device, developed by a Cornell graduate student, fits in the palm of a hand, is battery-powered and packs enough punch to stabilize a gunshot wound or deliver drugs to brain cancer patients.

21 Dec 2008

FDA issues complete response to biologics license application for ustekinumab

Centocor, Inc., has announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter for its Biologics License Application (BLA) for ustekinumab.

21 Dec 2008

Well balanced diet improves blood glucose tolerance and blood lipid levels

A study published by the Journal of the American Medical Association ( JAMA ) on 16 December 2008 has found that those with type 2 diabetes who had a diet high in low-glycemic foods such as nuts, beans and lentils had greater improvement in glycemic control and risk factors for coronary heart disease than those on a diet with an emphasis on high-cereal fibre.

21 Dec 2008

Poeple who eat out often more likely to be obese

In small towns in the Midwestern United States, people who eat out often at buffets and cafeterias and who perceive their community to be unpleasant for physical activity are more likely to be obese.

21 Dec 2008

Drinkers with the ADH1C gene at greater risk of colorectal cancer

Chronic drinking is a risk factor for colorectal cancer, possibly through the effects of acetaldehyde, which is created by the alcohol dehydrogenase (ADH) enzyme.

21 Dec 2008

Safer optic nerve decompression surgery

Knowing about variations in the location of the optic nerve and ophthalmic artery can aid surgeons in performing optic nerve decompression - a delicate operation performed in patients with vision loss resulting from head injury, reports a study in the November Journal of Craniofacial Surgery.

21 Dec 2008

World-first technique used to repair an injured donor lung

For the first time in the world, transplant surgeons at Toronto General Hospital, University Health Network used a new technique to repair an injured donor lung that was unsuitable for transplant, and then successfully transplanted it into a patient.

21 Dec 2008

Botulinum toxin used to treat patients with masseteric muscle hypertrophy

For patients with an uncommon condition causing a swollen appearance of the lower face, treatment with botulinum toxin type A (Botox) provides an effective alternative to plastic surgery, according to a study in the November Journal of Craniofacial Surgery.

21 Dec 2008

vCJD blood test achieves 100% accuracy

Amorfix Life Sciences has announced it achieved 100% sensitivity and 100% specificity in a second blinded trial of human blood samples using its EP-vCJD blood test in collaboration with the National Institute for Biological Standards and Control (NIBSC) in the United Kingdom.

21 Dec 2008

AstraZeneca submits sNDA for NEXIUM (esomeprazole magnesium)

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for NEXIUM(R) (esomeprazole magnesium) to seek approval for the short-term (up to 6 weeks) treatment of gastroesophageal reflux disease (GERD) in pediatric patients ages 0 to 1 year old.

21 Dec 2008

AstraZeneca and MAP Pharmaceuticals announce collaboration on Unit Dose Budesonide

AstraZeneca and MAP Pharmaceuticals, Inc. have announced an exclusive worldwide agreement to develop and commercialize Unit Dose Budesonide (UDB), MAP Pharmaceuticals' proprietary nebulized formulation of budesonide.

21 Dec 2008